ClinicalTrials.gg
Drug

Tenapanor clinical trials

Also written AZD1722, RDX5791 and IBSRELA.

studies test it
37
open now
3
in phase 3
15
first study started
2010

How each study uses tenapanor is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the tenapanor studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
12 Sept 2019 · IBSRELA · NDA 211801 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tenapanor
22
Tenapanor 25 mg bid
2
RDX5791, AZD1722
2

Brand

IBSRELA
4
XPHOZAH
1

Development codes

AZD1722
13
RDX5791
10
KHK7791
7

Studies by the year they started

37 studies that test it; most in 2013 (7)

Studies that test tenapanor, by start year
YearStudies
20101
20112
20137
20143
20152
20162
20182
20194
20201
20214
20221
20232
20243
20252
20261

By phase

A phase 1/2 study counts in both.

Phase 1
9
Phase 2
11
Phase 3
15
Phase 4
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 33 · Other 4

Ardelyx (26) · Kyowa Kirin Co., Ltd. (7) · Massachusetts General Hospital (1) · University of Texas Southwestern Medical Center (1) · Kyle Staller, MD, MPH (1) · Cedar Valley Digestive Health Center (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test tenapanor, phase 3 first.

Studies

Open first, then newest update. How each study uses tenapanor is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 37

See all 37 studies that test tenapanor →

Codes

What other systems call tenapanor · ClinicalTrials.gg INT000263

  • MeSH (NLM) C000599417tenapanorConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) WYD79216A6TENAPANORConfirmed FDA, NLM, Wikidata
  • RxNorm 2199674One source FDA
  • Wikidata Q17122912tenapanorConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152555TenapanorOne source FDA
  • DrugBank DB11761One source Wikidata

Also registered as tenapanor hydrochloride (UNII 50605O2ZNS · RxNorm 2199673).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.